Background Low muscle mass (LMM) and low muscle attenuation (LMA) reflect low muscle
quantity and low muscle quality, respectively. Both are associated with a poor outcome in …

Purpose Body composition parameters including low muscle mass, muscle attenuation
(which reflects muscle quality) and adipose tissue measurements have emerged as …

Purpose Breast cancer is the most common cancer and leading cause of cancer death in
women. Body composition parameters, especially those related to muscle, have become a …

In several diseases, low muscle mass has been revealed as an unfavorable prognostic
factor for outcome. Whether this holds true in patients with solid malignancies as well has …

Background Muscle dysfunction and sarcopenia have been associated with poor
performance status, an increased mortality risk, and greater side effects in oncologic …

Skeletal muscle loss, commonly known as sarcopenia, is highly prevalent and prognostic of
adverse outcomes in oncology. However, there is limited information on adults with early …

Purpose: Severe skeletal muscle (SM) loss (sarcopenia) is associated with poor cancer
outcomes, including reduced survival and increased toxicity. This study investigates SM …

Low skeletal muscle density (SMD) and low skeletal muscle index (SMI) are associated with
poor overall survival (OS) in patients with various types of cancer. We retrospectively studied …

Objectives Low skeletal muscle mass (LSMM) predicts relevant clinical outcomes in
oncologic patients. The purpose of this study was to perform a meta-analysis of data …

Background Identifying predictors of treatment toxicity and overall survival (OS) is important
for selecting patients who will benefit from chemotherapy. In younger patients with cancer …